Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observer-Blind, Randomized, Parallel-Group Study to Compare the Efficacy of Two Rizatriptan Prescribing Portions for the Treatment of Migraine

NCT00397254 is registered in ClinicalTrials.gov with Clinvest as lead sponsor.

NCT NCT00397254
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00397254 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observer-Blind, Randomized, Parallel-Group Study to Compare the Efficacy of Two Rizatriptan Prescribing Portions for the Treatment of Migraine
Lead sponsor
Clinvest
Phase
Phase 4
Overall status
Completed
Start date
December 31, 2006
Completion date
January 31, 2008
Enrollment
197 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

migraine